Mgr. Kateřina Černá
odborná pracovnice - PhD student
2017
- PAVLASOVA, G; BORSKY, M; SVOBODOVA, V; MUSILOVA, K; CERNA, K; SEDA, V; OSICKOVA, J; BRYCHTOVA, Y; DOUBEK, M; POSPISILOVA, S; MAYER, J; MRAZ, M, 2017:BCR SIGNALLING PROFICIENT CHRONIC LYMPHOCYTIC LEUKAEMIA B CELLS ARE PRONE TO RITUXIMAB MEDIATED ELIMINATION IN VIVO. HAEMATOLOGICA 102 , p. 412 - 412.
- PAVLASOVA, G; MUSILOVA, K; SEDA, V; CERNA, K; VOJACKOVA, E; SVOBODOVA, V; MRAZ, M, 2017:The identification of combinatorial therapeutic approaches with BCR inhibitors in B cell malignancies. MOLECULAR CANCER THERAPEUTICS 16 (10)
2016
- PAVLASOVA, G; BORSKY, M; SEDA, V; CERNA, K; OSICKOVA, J; DOUBEK, M; MAYER, J; CALOGERO, R; POSPISILOVA, S; DAVIDS, M; BROWN, J; MRAZ, M, 2016:IBRUTINIB INHIBITS CD20 UP-REGULATION ON CLL B CELLS MEDIATED BY THE CXCR4/SDF-1 AXIS. HAEMATOLOGICA 101 , p. 47 - 47.
- PAVLASOVA, G; BORSKY, M; SEDA, V; CERNA, K; OSICKOVA, J; DOUBEK, M; MAYER, J; CALOGERO, R; TRBUSEK, M; POSPISILOVA, S; DAVIDS, MS; KIPPS, TJ; BROWN, JR; MRAZ, M, 2016:Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis. BLOOD 128 (12), p. 1609 - 1613.
2015
- PAVLASOVA, G; SEDA, V; BORSKY, M; CERNA, K; OSICKOVA, J; MAYER, J; POSPISILOVA, S; DAVIDS, MS; BROWN, JR; MRAZ, M, 2015:Microenvironmental Interactions up-Regulate CD20 Expression in CLL B Cells through the CXCR4/SDF-1 Axis: Implications for CD20-Targeting Antibodies and the Use of BCR-Inhibitors in Combination. BLOOD 126 (23)